MyFinsight
Home
About
Contact
eypt: the income statement
Download
Download image
Comprehensive income (loss)
-$59,645K
(-105.80%↓ Y/Y)
Unrealized gain (loss) on
available-for-sale securities
$87K
(-77.04%↓ Y/Y)
Net loss
-$59,732K
(-103.44%↓ Y/Y)
Interest and other
income, net
$2,293K
(-32.30%↓ Y/Y)
Net loss before
income taxes
-$59,732K
Total other income,
net
$2,293K
(-32.30%↓ Y/Y)
Royalty
$234K
License And
Collaboration Agreement
$150K
Product
$582K
Loss from operations
-$62,025K
(-89.40%↓ Y/Y)
Total revenues
$966K
(-90.82%↓ Y/Y)
Total operating
expenses
$62,991K
General and
administrative
$14,490K
(11.72%↑ Y/Y)
Sales and marketing
$26K
(8.33%↑ Y/Y)
Research and development
$47,754K
(61.65%↑ Y/Y)
Cost of sales
$721K
Back
Back
Income Statement
source: myfinsight.com
EyePoint Pharmaceuticals, Inc. (EYPT)
EyePoint Pharmaceuticals, Inc. (EYPT)